CVE-2023-20223
CVE-2023-20223 is a high-severity vulnerability in Cisco Dna Center with a CVSS 3.x base score of 8.6. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-284.
Key facts
- Severity: High (CVSS 3.x base score 8.6)
- EPSS exploit prediction: 0% (38th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-284
- Affected product: Cisco Dna Center
- Published:
- Last modified:
Description
A vulnerability in Cisco DNA Center could allow an unauthenticated, remote attacker to read and modify data in a repository that belongs to an internal service on an affected device. This vulnerability is due to insufficient access control enforcement on API requests. An attacker could exploit this vulnerability by sending a crafted API request to an affected device. A successful exploit could allow the attacker to read and modify data that is handled by an internal service on the affected device.
Frequently asked questions
- What is CVE-2023-20223?
- A vulnerability in Cisco DNA Center could allow an unauthenticated, remote attacker to read and modify data in a repository that belongs to an internal service on an affected device. This vulnerability is due to insufficient access control enforcement on API requests. An attacker could exploit this vulnerability by sending a crafted API request to an affected device. A successful exploit could allow the attacker to read and modify data that is handled by an internal service on the affected device.
- How severe is CVE-2023-20223?
- CVE-2023-20223 has a CVSS 3.x base score of 8.6, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity low, and availability low.
- Is CVE-2023-20223 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (38th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2023-20223?
- CVE-2023-20223 affects Cisco Dna Center. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2023-20223?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
- When was CVE-2023-20223 published?
- CVE-2023-20223 was published on 2023-09-27 and last updated on 2026-06-17.
References
Affected products (1)
- cpe:2.3:a:cisco:dna_center:*:*:*:*:*:*:*:*
More vulnerabilities in Cisco Dna Center
- CVE-2021-44228 — Critical (CVSS 10.0): Apache Log4j2 2.0-beta9 through 2.15.0 (excluding security releases 2.12.2, 2.12.3, and 2.3.1) JNDI features used in…
All CVEs affecting Cisco Dna Center →
Other CWE-284 (Improper Access Control) vulnerabilities
- CVE-2026-50746 — Critical (CVSS 10.0): A malicious actor with access to the network could exploit an Improper Access Control vulnerability found in UniFi…
- CVE-2026-46978 — Critical (CVSS 10.0): Vulnerability in the Oracle Solaris product of Oracle Systems (component: Remote Administration Daemon). The…
- CVE-2026-35308 — Critical (CVSS 10.0): Vulnerability in the Oracle Coherence product of Oracle Fusion Middleware (component: Centralized Third Party Jars).…
- CVE-2026-35307 — Critical (CVSS 10.0): Vulnerability in the Oracle Coherence product of Oracle Fusion Middleware (component: Core). Supported versions that…
- CVE-2026-46695 — Critical (CVSS 10.0): Boxlite is a sandbox service that allows users to create lightweight virtual machines (Boxes) and launch OCI containers…
- CVE-2026-46840 — Critical (CVSS 10.0): Vulnerability in Oracle REST Data Services (component: Backend-as-a-Service). Supported versions that are affected are…
Browse all CWE-284 (Improper Access Control) vulnerabilities →